Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Amortization - Intangibles (2024 - 2025)

Pyxis Oncology has reported Amortization - Intangibles over the past 2 years, most recently at $375000.0 for Q4 2025.

  • Quarterly Amortization - Intangibles fell 75.54% to $375000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.0 million through Dec 2025, down 51.55% year-over-year, with the annual reading at $3.0 million for FY2025, 51.55% down from the prior year.
  • Amortization - Intangibles was $375000.0 for Q4 2025 at Pyxis Oncology, down from $532000.0 in the prior quarter.
  • Over five years, Amortization - Intangibles peaked at $1.7 million in Q3 2024 and troughed at $375000.0 in Q4 2025.